Concr

Provider of a platform predicting therapeutic response and outcome for cancer

placeLondon, England, United Kingdom calendar_todayFounded 2018 groups6 employees language concr.co

Registered entities

Social engagement

Social engagement: 1.6K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital675%
Angel & family office113%
Accelerator & incubator113%

Recent activity

9 Jun 2026
Milestone
cert
21 May 2026
Partnership
Debiopharm
15 Apr 2026
Event
Anglonordic
Coming soon